ECSP034483A - PHARMACEUTICAL COMPOUNDS - Google Patents
PHARMACEUTICAL COMPOUNDSInfo
- Publication number
- ECSP034483A ECSP034483A ECSP034483A ECSP034483A EC SP034483 A ECSP034483 A EC SP034483A EC SP034483 A ECSP034483 A EC SP034483A EC SP034483 A ECSP034483 A EC SP034483A
- Authority
- EC
- Ecuador
- Prior art keywords
- compounds
- conditions
- pharmaceutical compounds
- ifata
- adhesions
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 101800004538 Bradykinin Proteins 0.000 abstract 1
- 208000032544 Cicatrix Diseases 0.000 abstract 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 abstract 1
- 102100035792 Kininogen-1 Human genes 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000003176 fibrotic effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 230000037387 scars Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona compuestos de fórmula (1), estos compuestos son una clase de inhibidores de IFATa. Dichos compuestos son adecuados para uso en el tratamiento de afecciones tales como trombosis, aterosclerosis, adherencias, cicatrices, dérmicas, cáncer, afecciones fibróticas, enfermedades inflamatorias y aquellas afecciones que se benefician del mantenimiento o la potenciación de los niveles de bradiquinina en el cuerpo.The present invention provides compounds of formula (1), these compounds are a class of IFATa inhibitors. Such compounds are suitable for use in the treatment of conditions such as thrombosis, atherosclerosis, adhesions, scars, dermal, cancer, fibrotic conditions, inflammatory diseases and those conditions that benefit from the maintenance or enhancement of bradykinin levels in the body.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0020346A GB0020346D0 (en) | 2000-08-17 | 2000-08-17 | Pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034483A true ECSP034483A (en) | 2003-03-31 |
Family
ID=9897839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034483 ECSP034483A (en) | 2000-08-17 | 2003-02-14 | PHARMACEUTICAL COMPOUNDS |
Country Status (4)
| Country | Link |
|---|---|
| EC (1) | ECSP034483A (en) |
| GB (1) | GB0020346D0 (en) |
| GT (1) | GT200100164A (en) |
| ZA (1) | ZA200301230B (en) |
-
2000
- 2000-08-17 GB GB0020346A patent/GB0020346D0/en not_active Ceased
-
2001
- 2001-08-14 GT GT200100164A patent/GT200100164A/en unknown
-
2003
- 2003-02-14 ZA ZA200301230A patent/ZA200301230B/en unknown
- 2003-02-14 EC ECSP034483 patent/ECSP034483A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200100164A (en) | 2002-06-25 |
| ZA200301230B (en) | 2004-04-21 |
| GB0020346D0 (en) | 2000-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2001000233A (en) | PHARMACEUTICAL COMPOUNDS | |
| AR028296A1 (en) | SYNERGISTIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| HN2001000244A (en) | SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS. | |
| MXPA03010487A (en) | Diarylurea derivatives useful as anti-inflammatory agents. | |
| AR035637A1 (en) | BETAMIMETICOS OF LONG ACTION, PROCEDURE FOR ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS | |
| CL2018002924A1 (en) | Bromodomain Inhibitors | |
| UY26249A1 (en) | SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES LAW 17164 ART. 127 | |
| PA8468401A1 (en) | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | |
| UY27224A1 (en) | INHIBITORS OF RHO-QUINASA | |
| ECSP003610A (en) | PYRIMIDINE-2,4,6 METALOPROTEIN INHIBITING TRIONES | |
| AR016993A1 (en) | INTRANASAL FORMULATIONS TO TREAT SEXUAL DISORDERS | |
| PA8680701A1 (en) | OXINDOL DERIVATIVES | |
| ES2151277T3 (en) | COMPOSITIONS INCLUDING CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND TAXOTERE. | |
| PY2261702A (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS-RELATED DISEASES | |
| CY1106026T1 (en) | ARYLSULFONAMIDES AS SEPOTONIN ANTAGONISTS FOR THE TREATMENT OF OBESITY | |
| MX2019014667A (en) | Treatment of cutaneous disorders. | |
| ES2174921T3 (en) | HIV PROTEASE INHIBITORS. | |
| UY27208A1 (en) | A COMBINATION THAT INCLUDES COMBRETASTATINE AND ANTICARCINOGEN AGENTS. | |
| CO2024014485A2 (en) | Heterocyclic compounds modulating BCL6 as ligand-directed degraders | |
| PA8571501A1 (en) | INHIBITORS TRIARILOXIARILOXIPIRIMIDIN-2,4,6-METALOPROTEINASE TRION | |
| AR020563A1 (en) | TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE | |
| ES2064119T3 (en) | NEW DERIVATIVES OF AMINOBENZOSULTAM AS LIPOXIGENASE INHIBITORS. | |
| ECSP034483A (en) | PHARMACEUTICAL COMPOUNDS | |
| CO2025006082A2 (en) | Compounds and their use for the treatment of hemoglobinopathies | |
| CR6857A (en) | PHARMACEUTICAL COMPOUNDS |